Literature DB >> 15833724

Development of an advocacy curriculum in a pediatric residency program.

Clyde J Wright1, Megan A Moreno, Murray L Katcher, Gwen C McIntosh, Marlon P Mundt, Timothy E Corden.   

Abstract

BACKGROUND: The Accreditation Council for Graduate Medical Education now requires pediatric residency programs to include advocacy training, but few guidelines for development exist.
PURPOSE: To determine faculty and resident attitudes regarding advocacy training, and to develop consensus on the best method to teach and learn advocacy.
METHODS: Pediatric residents (n = 28) and faculty (n = 51) participated in a survey about experience and training in advocacy, identified issues important to address in an advocacy curriculum, and rated a variety of learning methods.
RESULTS: Nearly 90% of residents felt advocacy training was needed, and 82% felt advocacy activities would continue following residency. Faculty and residents agreed that participation in short-term or longitudinal projects was the best way to teach and learn advocacy skills. Respondents identified and ranked 45 issues to address through advocacy efforts and training, and these results were used to develop and implement an advocacy curriculum.
CONCLUSIONS: Residents and faculty were interested in incorporating an advocacy curriculum, and survey results were used to guide curriculum development.

Mesh:

Year:  2005        PMID: 15833724     DOI: 10.1207/s15328015tlm1702_8

Source DB:  PubMed          Journal:  Teach Learn Med        ISSN: 1040-1334            Impact factor:   2.414


  2 in total

1.  Educating health care professionals in advocacy for childhood obesity prevention in their communities: integrating public health and primary care in the Be Our Voice project.

Authors:  Marianne E McPherson; Rachelle Mirkin; Priya Nair Heatherley; Charles J Homer
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

2.  Advocacy in neurology.

Authors:  Apoorva Pauranik
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.